Top compounds associated with response to ZNF665


Feature Type Standardized
Nominal ANOVA
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.075 0.03
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.084 0.03
mRNA GSK2126458 GDSC1000 pan-cancer AAC 0.068 0.03
mRNA Gemcitabine gCSI pan-cancer AAC -0.11 0.04
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.08 0.04
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.04
mRNA ZM-447439 GDSC1000 pan-cancer AAC 0.077 0.04
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.04
mRNA Doxorubicin gCSI pan-cancer AAC -0.11 0.04
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.078 0.04
Download CSV